Tolerance to the anticonvulsant effect of morphine in mice: Blockage by ultra-low dose naltrexone

Epilepsy Research

Volumn 83, Issue 2-3, 2009, Pages 261-264

  Roshanpour, Maryam ^a   Ghasemi, Mehdi ^b   Riazi, Kiarash ^c   Rafiei Tabatabaei, Neda ^a   Ghahremani, Mohammad Hossein ^a   Dehpour, Ahmad Reza ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Clonic seizure threshold; Excitatory opioid receptor; Mice; Morphine; Opioid tolerance; Ultra low dose naltrexone

Indexed keywords

MORPHINE; NALTREXONE; OPIATE RECEPTOR; PENTETRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERABILITY; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE SUSCEPTIBILITY; SEIZURE THRESHOLD; SWISS WEBSTER MOUSE;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG TOLERANCE; MALE; MICE; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; PENTYLENETETRAZOLE; SEIZURES;

EID: 58849144606     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2008.10.011     Document Type: Article

References (24)

1. sα: enhancement following morphine exposure. Brain Res. Mol. Brain Res. 135 (2005) 217-224
2. sα stimulation of adenylyl cyclase: relevance to opioid tolerance. Mol. Pharmacol. 54 (1998) 655-662
3. Crain S.M., and Shen K.F. Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. Trends Pharmacol. Sci. 11 (1990) 77-81
4. Crain S.M., and Shen K.F. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 10540-10544
5. Crain S.M., and Shen K.F. Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance, and dependence. Neurochem. Res. 21 (1996) 1347-1351
6. Crain S.M., and Shen K.F. Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions. Trends Pharmacol. Sci. 19 (1998) 358-365
7. Crain S.M., and Shen K.F. Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability. Pain 84 (2000) 121-131
8. Harrison L.M., Kastin A.J., and Zadina J.E. Opiate tolerance and dependence: receptors, G-proteins, and antiopiates. Peptides 19 (1998) 1603-1630
9. Homayoun H., Khavandgar S., and Dehpour A.R. The role of alpha2-adrenoceptors in the modulatory effects of morphine on seizure susceptibility in mice. Epilepsia 43 (2002) 797-804
10. Homayoun H., Khavandgar S., Namiranian K., Gaskari S.A., and Dehpour A.R. The role of nitric oxide in anticonvulsant and proconvulsant effects of morphine in mice. Epilepsy Res. 48 (2002) 33-41
11. Honar H., Riazi K., Homayoun H., Sadeghipour H., Rashidi N., Ebrahimkhani M.R., Mirazi N., and Dehpour A.R. Ultra-low dose naltrexone potentiates the anticonvulsant effect of low dose morphine on clonic seizures. Neuroscience 129 (2004) 733-742
12. Lauretti G.R., Ahmad I., and Pleuvry B.J. The activity of opioid analgesics in seizure models utilizing N-methyl-dl-aspartic acid, kainic acid, bicuculline and pentylenetetrazole. Neuropharmacology 33 (1994) 155-160
13. Löscher W., Hönack D., Fassbender C.P., and Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models. Epilepsy Res. 8 (1991) 171-189
14. Mandhane S.N., Aavula K., and Rajamannar T. Timed pentylenetetrazol infusion test: a comparative analysis with s.c. PTZ and MES models of anticonvulsant screening in mice. Seizure 16 (2007) 636-644
15. Niaki S.E., Shafaroodi H., Ghasemi M., Shakiba B., Fakhimi A., and Dehpour A.R. Mouth breathing increases the pentylenetetrazole-induced seizure threshold in mice: a role for ATP-sensitive potassium channels. Epilepsy Behav. 13 (2008) 284-289
16. Sagratella S., and Massotti M. Convulsant and anticonvulsant effects of opioids: relationship to GABA-mediated transmission. Neuropharmacology 21 (1982) 991-1000
17. Shafaroodi H., Asadi S., Sadeghipour H., Ghasemi M., Ebrahimi F., Tavakoli S., Hajrasouliha A.R., and Dehpour A.R. Role of ATP-sensitive potassium channels in the biphasic effects of morphine on pentylenetetrazole-induced seizure threshold in mice. Epilepsy Res. 75 (2007) 63-69
18. Shen K.F., and Crain S.M. Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture. Brain Res. 491 (1989) 227-242
19. Shen K.F., and Crain S.M. Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence. Brain Res. 636 (1994) 286-297
20. Shen K.F., and Crain S.M. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice. Brain Res. 757 (1997) 176-190
21. Tso P.H., and Wong Y.H. Molecular basis of opioid dependence: role of signal regulation by G-proteins. Clin. Exp. Pharmacol. Physiol. 30 (2003) 307-316
22. Wang H.Y., Frankfurt M., and Burns L.H. High-affinity naloxone binding to filamin a prevents mu opioid receptor-Gs coupling underlying opioid tolerance and dependence. PLoS ONE 3 (2008) e1554
23. Wang H.Y., Friedman E., Olmstead M.C., and Burns L.H. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling. Neuroscience 135 (2005) 247-261
24. Williams J.T., Christie M.J., and Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol. Rev. 81 (2001) 299-343